Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$733
|
$693B |
12.4x |
29.4x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$177
|
$459B |
5.0x |
13.7x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$210
|
$436B |
7.4x |
16.1x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$237B |
3.7x |
8.3x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$493
|
$215B |
4.9x |
19.7x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$288
|
$203B |
5.8x |
10.9x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.6x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$206
|
$162B |
6.6x |
21.1x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$113
|
$160B |
5.6x |
11.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$133B |
2.8x |
9.3x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$391
|
$95.4B |
8.2x |
24.5x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$156
|
$74.7B |
7.9x |
18.2x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$447
|
$57.0B |
18.6x |
123.7x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$581
|
$56.8B |
4.1x |
11.5x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$647
|
$52.8B |
12.8x |
37.4x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$191
|
$45.9B |
2.9x |
12.3x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$126
|
$37.6B |
5.5x |
19.2x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$278
|
$29.0B |
2.1x |
12.5x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1301
|
$28.9B |
7.3x |
23.3x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$27.5B |
63.1x |
-28.2x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$182
|
$26.4B |
2.5x |
12.5x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.2B |
1.9x |
6.1x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$340
|
$24.2B |
9.9x |
42.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$23.2B |
2.4x |
7.1x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$168
|
$22.3B |
11.4x |
-89.2x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$22.1B |
7.5x |
8.1x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$302
|
$19.1B |
6.2x |
17.2x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$17.3B |
N/A |
-51.0x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$100
|
$17.3B |
4.0x |
15.1x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$178
|
$17.0B |
2.1x |
10.3x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$85
|
$14.1B |
3.1x |
14.3x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$476
|
$13.4B |
5.8x |
26.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$140
|
$13.3B |
5.0x |
20.9x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$90
|
$12.8B |
4.6x |
15.1x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$12.8B |
2.8x |
14.5x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$128
|
$11.5B |
2.8x |
9.8x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$11.0B |
28.4x |
-23.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$305
|
$10.7B |
3.4x |
6.5x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$47
|
$10.6B |
3.5x |
25.5x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$163
|
$10.6B |
2.7x |
10.9x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$46
|
$10.6B |
5.2x |
14.0x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.4B |
3.4x |
12.2x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$73
|
$9.5B |
7.8x |
12.0x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$9.5B |
4.2x |
11.8x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$130
|
$9.2B |
1.2x |
7.3x |
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$67
|
$9.1B |
10.6x |
-39.2x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$438
|
$9.1B |
14.2x |
-28.0x |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$55
|
$8.8B |
7.2x |
20.5x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$100
|
$8.0B |
3.0x |
-5.6x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$7.0B |
8.7x |
N/A |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$14
|
$6.9B |
N/A |
N/A |
Repligen
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$122
|
$6.9B |
9.9x |
51.2x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$103
|
$6.7B |
40.1x |
-32.7x |
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$16
|
$6.7B |
5.9x |
11.7x |
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$23
|
$6.6B |
5.1x |
20.6x |
RadNet
|
United States of America |
Medical Imaging & Diagnostics,
Laboratory Services
|
$72
|
$6.5B |
3.4x |
22.7x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$24
|
$6.5B |
1.5x |
8.6x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$121
|
$6.0B |
11.0x |
-33.8x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$5.9B |
7.3x |
-14.4x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$5.8B |
6.4x |
-43.8x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.5B |
1.9x |
8.3x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$5.1B |
1017.5x |
-5.5x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$24
|
$5.0B |
2.1x |
-1.3x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$4.8B |
483.6x |
-8.8x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$4.7B |
9.3x |
41.8x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$77
|
$4.5B |
N/A |
-13.0x |
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$16
|
$4.5B |
1.3x |
7.2x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$4.3B |
92.0x |
-13.7x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$68
|
$4.3B |
3.8x |
11.5x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$4.2B |
71.1x |
-7.3x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$17
|
$4.1B |
8.6x |
19.8x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$43
|
$4.0B |
39.7x |
-45.0x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$29
|
$3.8B |
2.6x |
10.0x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$12
|
$3.7B |
143.0x |
-3.5x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$3.7B |
8.4x |
-96.4x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$3.7B |
3.6x |
25.6x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$55
|
$3.7B |
2.4x |
6.1x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.6B |
6.0x |
17.7x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$148
|
$3.6B |
10.2x |
28.3x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$3.6B |
4.1x |
214.5x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$3.4B |
48.4x |
-17.0x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$68
|
$3.4B |
37.2x |
N/A |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$52
|
$3.2B |
94.6x |
-6.0x |
MoonLake
|
United States of America |
Drug Development & Therapeutics
|
$56
|
$3.2B |
N/A |
-15.8x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$3.2B |
N/A |
N/A |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$59
|
$3.1B |
16.5x |
22473.7x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$3.0B |
N/A |
-9.5x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$33
|
$2.9B |
753.4x |
-8.8x |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$162
|
$2.9B |
14.7x |
40.8x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$2.8B |
N/A |
N/A |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.6B |
33.3x |
N/A |
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$8
|
$2.6B |
4.3x |
35.9x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$2.5B |
500.2x |
-7.6x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$2.5B |
3.7x |
135.1x |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$94
|
$2.5B |
3.2x |
12.4x |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$2.4B |
3.9x |
-5.5x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$31
|
$2.4B |
N/A |
N/A |
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$28
|
$2.4B |
47.5x |
N/A |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.4B |
33.9x |
-8.7x |